Synthesis of Zinc Oxide Nanoparticles from Lactic Acid Bacteria Isolated from Various Foods and Investigation of Their in-vitro Efficacy Against the Acne Pathogen Cutibacterium acnes
Project no. 32720 · Status: Kapanmış (Yayın bekleniyor) · 2024
Summary
<p><span style="color: rgb(0, 0, 0);">Acne vulgaris is a chronic inflammatory skin disorder in which </span><em style="color: rgb(0, 0, 0);">Cutibacterium acnes</em><span style="color: rgb(0, 0, 0);"> plays a major role in disease pathogenesis. It ranks among the most prevalent diseases worldwide and can negatively a!ect individuals not only physically but also psychologically by reducing their quality of life and emotional well-being. The prolonged and inappropriate use of antibiotics in acne treatment may promote the emergence of antibiotic-resistant microorganisms. Increasing antimicrobial resistance can limit the therapeutic efficacy of conventional treatments and highlights the need to develop alternative antimicrobial strategies. In this context, nanoparticles produced through green synthesis have attracted considerable attention as environmentally sustainable antibacterial agents because these approaches can reduce the toxic by-products and hazardous waste associated with conventional chemical synthesis methods.</span></p><p></p><p><span style="color: rgb(0, 0, 0);">In the present study, zinc oxide nanoparticles (ZnO NPs) were biologically synthesized using extracellular bioactive compounds produced by lactic acid bacteria. UV–visible spectrophotometry and scanning electron microscopy (SEM) were employed to confirm nanoparticle formation and characterize the resulting structures, while Fourier-transform infrared spectroscopy (FT-IR) was used to identify the functional groups associated with the synthesized nanoparticles. The antibacterial activity of ZnO NPs synthesized using isolates obtained from Tulum cheese and identified by sequence analysis as </span><em style="color: rgb(0, 0, 0);">Lentilactobacillus kefiri</em><span style="color: rgb(0, 0, 0);"> and </span><em style="color: rgb(0, 0, 0);">Lactococcus lactis</em><span style="color: rgb(0, 0, 0);"> was evaluated against </span><em style="color: rgb(0, 0, 0);">C. acnes </em><span style="color: rgb(0, 0, 0);">ATCC 11827. The ZnO NPs synthesized using </span><em style="color: rgb(0, 0, 0);">Lentilactobacillus kefiri </em><span style="color: rgb(0, 0, 0);">and </span><em style="color: rgb(0, 0, 0);">Lactococcus lactis </em><span style="color: rgb(0, 0, 0);">produced inhibition zones of 13.0 ± 0.17 mm and 9.0 ± 0.15 mm, respectively. Their minimum inhibitory concentrations were determined as 0.125 mg/mL and 0.25 mg/mL, respectively. Furthermore, at concentrations corresponding to 10 × MIC, both ZnO NP preparations caused a >4.49 log reduction in the viable bacterial population within 3 h, reducing the bacterial counts to below the detection limit.</span></p><p></p><p></p>